.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Merck
Deloitte
QuintilesIMS
Fuji
McKinsey
Harvard Business School
Federal Trade Commission
Mallinckrodt
Cerilliant
US Department of Justice

Generated: November 24, 2017

DrugPatentWatch Database Preview

Cilastatin sodium; imipenem - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for cilastatin sodium; imipenem and what is the scope of cilastatin sodium; imipenem freedom to operate?

Cilastatin sodium; imipenem
is the generic ingredient in two branded drugs marketed by Hospira Inc, Merck, and Acs Dobfar, and is included in six NDAs. Additional information is available in the individual branded drug profile pages.

There are sixteen drug master file entries for cilastatin sodium; imipenem. Four suppliers are listed for this compound.

Summary for cilastatin sodium; imipenem

Pharmacology for cilastatin sodium; imipenem

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Merck
PRIMAXIN
cilastatin sodium; imipenem
INJECTABLE;INJECTION062756-002Jan 8, 1987DISCNNoNo► Subscribe► Subscribe► Subscribe
Merck
PRIMAXIN
cilastatin sodium; imipenem
POWDER;INTRAVENOUS050587-001Nov 26, 1985APRXYesYes► Subscribe► Subscribe► Subscribe
Merck
PRIMAXIN
cilastatin sodium; imipenem
POWDER;INTRAVENOUS050587-002Nov 26, 1985APRXYesYes► Subscribe► Subscribe► Subscribe
Hospira Inc
IMIPENEM AND CILASTATIN
cilastatin sodium; imipenem
POWDER;INTRAVENOUS090825-002Nov 16, 2011APRXNoNo► Subscribe► Subscribe► Subscribe
Merck
PRIMAXIN
cilastatin sodium; imipenem
POWDER;INTRAMUSCULAR050630-002Dec 14, 1990DISCNNoNo► Subscribe► Subscribe► Subscribe
Acs Dobfar
IMIPENEM AND CILASTATIN
cilastatin sodium; imipenem
POWDER;INTRAVENOUS090577-002Dec 21, 2011APRXNoNo► Subscribe► Subscribe► Subscribe
Merck
PRIMAXIN
cilastatin sodium; imipenem
INJECTABLE;INJECTION062756-001Jan 8, 1987DISCNNoNo► Subscribe► Subscribe► Subscribe
Hospira Inc
IMIPENEM AND CILASTATIN
cilastatin sodium; imipenem
POWDER;INTRAVENOUS090825-001Nov 16, 2011APRXNoNo► Subscribe► Subscribe► Subscribe
Acs Dobfar
IMIPENEM AND CILASTATIN
cilastatin sodium; imipenem
POWDER;INTRAVENOUS090577-001Dec 21, 2011APRXNoNo► Subscribe► Subscribe► Subscribe
Merck
PRIMAXIN
cilastatin sodium; imipenem
POWDER;INTRAMUSCULAR050630-001Dec 14, 1990DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: cilastatin sodium; imipenem

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Merck
PRIMAXIN
cilastatin sodium; imipenem
POWDER;INTRAMUSCULAR050630-001Dec 14, 1990► Subscribe► Subscribe
Merck
PRIMAXIN
cilastatin sodium; imipenem
POWDER;INTRAVENOUS050587-002Nov 26, 1985► Subscribe► Subscribe
Merck
PRIMAXIN
cilastatin sodium; imipenem
POWDER;INTRAVENOUS050587-001Nov 26, 1985► Subscribe► Subscribe
Merck
PRIMAXIN
cilastatin sodium; imipenem
POWDER;INTRAMUSCULAR050630-002Dec 14, 1990► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
McKinsey
US Army
Covington
Chinese Patent Office
QuintilesIMS
Farmers Insurance
Queensland Health
Healthtrust
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot